Drug
efgartigimod alfa and hyaluronidase (human recombinant)
Marketed as VYVGART HYTRULO.
Generic name
efgartigimod alfa and hyaluronidase (human recombinant)
Brand names
VYVGART HYTRULO
First FDA approval
2023-06-20
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761304 | VYVGART HYTRULO | 2023-06-20 | ARGENX BV |
Manufacturers
ARGENX BV
Frequently asked questions
When was efgartigimod alfa and hyaluronidase (human recombinant) FDA approved?
Earliest FDA approval on record: 2023-06-20.
What brand names are sold as efgartigimod alfa and hyaluronidase (human recombinant)?
VYVGART HYTRULO.
Sources
Appeal a efgartigimod alfa and hyaluronidase (human recombinant) denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com